Intra-abdominal Abscess for FRCPath Part 2 Causes Diagnosis and Management from a UK Microbiologist Perspective
A patient with fever after bowel surgery may have atelectasis, a line infection, pneumonia, urinary sepsis, or a leak with an abscess forming deep in the abdomen. The clinical signs often overlap. The microbiology opinion matters because the right answer is rarely “give broader antibiotics”. The best outcome usually comes from early recognition, timely imaging, drainage where possible, and antimicrobial treatment that matches the likely source and patient risk factors.
This article covers intra-abdominal abscesses from the perspective of a UK Consultant Microbiologist, with an exam-focused approach for FRCPath Medical Microbiology Part 2. It is written for education and revision, not as patient-specific clinical advice. Local antimicrobial guidelines and specialist advice should guide real patient care.
What an intra-abdominal abscess is and how to classify it
An intra-abdominal abscess is a localised collection of pus within the abdominal cavity or abdominal viscera. It forms when infection, tissue necrosis, perforation, or contamination overwhelms local host defences and becomes walled off by inflammatory tissue.
The term covers a range of anatomical and microbiological syndromes. In exams, start by classifying the abscess by site, source, and healthcare exposure. That framing predicts the likely organisms, guides sampling, and shapes empirical treatment.
Classification by anatomical site
The common anatomical categories include:
Type | Typical context | Microbiology clues |
Intraperitoneal abscess | Perforated viscus, appendicitis, diverticulitis, postoperative leak | Mixed aerobic and anaerobic gut flora |
Subphrenic abscess | Postoperative state, perforated peptic ulcer, hepatobiliary source | Enterobacterales, anaerobes, streptococci |
Pelvic abscess | Diverticulitis, appendicitis, gynaecological infection, postoperative leak | Gut flora, anaerobes, sometimes genital tract organisms |
Hepatic abscess | Biliary disease, portal spread, haematogenous seeding, amoebiasis | Klebsiella spp., Escherichia coli, anaerobes, streptococci, Entamoeba histolytica in selected epidemiology |
Splenic abscess | Endocarditis, haematogenous spread, trauma, immunosuppression | Staphylococcus aureus, streptococci, Gram-negative bacilli, Candida in selected cases |
Pancreatic or peripancreatic collection | Necrotising pancreatitis, infected pseudocyst | Enterobacterales, enterococci, anaerobes, sometimes Candida |
Psoas or retroperitoneal abscess | Vertebral infection, Crohn’s disease, appendicitis, haematogenous spread | S. aureus for primary psoas, gut flora for secondary psoas |
Postoperative collection | Anastomotic leak, infected haematoma, retained material | Mixed flora, resistant Gram-negative bacilli, enterococci, Candida risk in selected patients |
Classification by source
From a microbiology viva perspective, source is often more useful than anatomy alone.
Community-acquired abscesses
These follow conditions such as appendicitis, diverticulitis, perforated ulcer, cholecystitis, or biliary obstruction. They are usually polymicrobial when bowel contents are involved.
Likely organisms include:
Enterobacterales Escherichia coli and Klebsiella species are common.
Anaerobes Bacteroides fragilis group is the key exam organism.
Streptococci Streptococcus anginosus group is strongly associated with abscess formation.
Enterococci More relevant in healthcare-associated infection, biliary infection, and high-risk patients, but can appear in community disease.
Healthcare-associated abscesses
These occur after abdominal surgery, endoscopy, peritoneal dialysis complications, invasive biliary procedures, or prolonged inpatient exposure. The microbiology may include resistant organisms.
Consider:
ESBL-producing Enterobacterales
AmpC-producing organisms such as Enterobacter cloacae complex
Pseudomonas aeruginosa, especially after healthcare exposure or previous broad-spectrum antibiotics
Enterococcus faecalis or Enterococcus faecium
Candida species in selected high-risk settings
Visceral abscesses
A liver abscess after biliary obstruction differs from a pyogenic abscess after portal spread from diverticulitis, and both differ from amoebic liver abscess. A psoas abscess from S. aureus bacteraemia differs from one arising from Crohn’s disease. These distinctions often decide the most important microbiology tests.
Common causes and risk factors
An abscess usually forms because organisms enter a normally sterile site and local clearance fails. The common mechanisms are perforation, leakage, haematogenous spread, contiguous spread, or infection of devitalised tissue.
Gastrointestinal perforation and leakage
Bowel perforation introduces a large inoculum of aerobic and anaerobic organisms. Common clinical contexts include:
Perforated appendicitis
Diverticulitis with contained perforation
Perforated colorectal cancer
Perforated peptic ulcer
Ischaemic bowel
Anastomotic leak after gastrointestinal surgery
Penetrating trauma
In these cases, an Intra-abdominal Abscess is usually polymicrobial. Gram stain may show a mixture of Gram-negative rods, Gram-positive cocci, and anaerobic-looking forms. That mixed pattern supports a gut source, although Gram stain cannot reliably identify anaerobes to species level.
Hepatobiliary and pancreatic sources
Biliary obstruction is a classic cause of liver abscess and cholangitic sepsis. Risk factors include gallstones, strictures, malignancy, biliary stents, and ERCP. Enterobacterales are common, and enterococci become more relevant after instrumentation or recurrent infection.
In necrotising pancreatitis, sterile necrosis may become infected. Infection is more likely when a patient deteriorates after initial improvement, develops persistent sepsis, or imaging shows gas within a collection. Cultures may grow enteric Gram-negative bacilli, enterococci, anaerobes, and sometimes Candida.
Haematogenous seeding
Splenic, hepatic, renal, or psoas abscesses may follow bacteraemia. S. aureus bacteraemia should prompt a deliberate search for metastatic infection, especially with back pain, persistent bacteraemia, prosthetic material, or abnormal inflammatory markers.
For a primary psoas abscess, S. aureus is a key organism. For a secondary psoas abscess, such as one arising from Crohn’s disease or appendicitis, mixed gut organisms are more likely.
Host and healthcare risk factors
Risk factors that should influence exam answers include:
Recent abdominal surgery
Anastomotic leak or bowel injury
Prior broad-spectrum antibiotic exposure
Recent hospitalisation or intensive care admission
Biliary stent, drain, or other foreign material
Immunosuppression, including steroids, chemotherapy, transplantation, and advanced HIV
Diabetes mellitus
Inflammatory bowel disease
Malignancy
Peritoneal dialysis
Previous colonisation or infection with resistant organisms
Travel or epidemiological risk for amoebiasis, tuberculosis, or melioidosis where relevant
The key FRCPath point is that risk factors do not just increase the chance of infection. They change the likely pathogen list and the balance between narrowing and broadening antimicrobial cover.
Clinical presentation and the differential diagnosis
Intra-abdominal abscesses can present dramatically or quietly. The classic pattern is fever, abdominal pain, raised inflammatory markers, and a preceding intra-abdominal event. Many patients do not read the textbook.
Typical clinical features
Common features include:
Fever or rigors
Localised abdominal pain
Guarding or tenderness
Ileus, nausea, vomiting, or poor oral intake
Diarrhoea or altered bowel habit
Jaundice in hepatobiliary disease
Shoulder tip pain with subphrenic irritation
Back, hip, or groin pain with psoas abscess
Persistent postoperative tachycardia or failure to recover
Raised C-reactive protein and neutrophilia
Sepsis, hypotension, or organ dysfunction in severe cases
Older adults, immunocompromised patients, and patients already receiving antibiotics may have muted signs. In postoperative cases, persistent ileus, ongoing pain, rising CRP, or unexplained tachycardia can be more useful than fever alone.
Differential diagnosis in a microbiology discussion
The differential depends on timing and context. For a postoperative patient with fever and high CRP, consider:
Anastomotic leak with abscess
Superficial or deep surgical site infection
Catheter-related bloodstream infection
Pneumonia or aspiration
Urinary tract infection
Clostridioides difficile infection after antibiotics
Venous thromboembolism
Drug fever
Pancreatitis
Biliary obstruction or cholangitis
For an abscess-like liver lesion, consider pyogenic abscess, amoebic abscess, hydatid disease, malignancy with necrosis, mycobacterial infection, and fungal microabscesses in selected immunocompromised patients.
Diagnostic approach from a UK microbiologist perspective
Diagnosis rests on clinical suspicion, imaging, and microbiological confirmation where possible. In the exam, show that the microbiologist is not a passive result reporter. The role includes advising on samples, interpreting cultures in context, and supporting source control decisions.
Initial bedside and laboratory assessment
A standard assessment includes:
Full blood count, renal function, liver function tests, clotting, CRP
Lactate and blood gas if sepsis is suspected
Blood cultures before antibiotics where this does not delay treatment
Urine testing when urinary source is possible
Stool testing for C. difficile if diarrhoea follows antibiotic exposure
Pregnancy testing where relevant before imaging or intervention
Blood cultures are often negative in localised abscesses, but positive cultures can change management. For example, S. aureus bacteraemia with a psoas collection raises concern for vertebral osteomyelitis or endocarditis. Klebsiella pneumoniae bacteraemia with liver abscess may prompt assessment for metastatic infection, particularly in hypervirulent syndromes described internationally.
Imaging
CT with intravenous contrast is often the main diagnostic test for suspected intra-abdominal abscess. It can show the size, site, gas, rim enhancement, communication with bowel, and feasibility of percutaneous drainage.
Ultrasound is useful for hepatobiliary disease, pelvic collections, and guided drainage in accessible sites. MRI can help for complex hepatobiliary disease, pelvic sepsis, spinal or psoas involvement, and when radiation avoidance matters.
Plain radiographs rarely diagnose an abscess directly. They may show ileus or free air, but they should not reassure clinicians if suspicion remains high.
Microbiological sampling
The best specimen is pus or fluid aspirated from the abscess, placed in a sterile universal container. Anaerobic transport should be used when possible. Tissue is valuable if there is debridement.
Avoid superficial swabs from drains or wounds when trying to define deep infection. Drain fluid from a long-standing drain often reflects colonisation and biofilm rather than the original abscess microbiology.
Send samples for:
Gram stain
Aerobic and anaerobic culture
Identification and antimicrobial susceptibility testing
Blood cultures if sepsis is present
Fungal culture where risk factors exist
Mycobacterial culture if TB or atypical mycobacterial infection is plausible
Parasitology or serology where amoebiasis is suspected
Histology if malignancy, actinomycosis, TB, or fungal infection is in the differential
Molecular testing may help in culture-negative disease after antibiotics, but it should be used with care. Broad-range 16S rRNA PCR can detect bacterial DNA, yet it may not provide susceptibility data and can detect non-viable organisms.
Interpreting culture results
The exam trap is over-interpreting every isolate. Interpretation depends on source, specimen quality, and host risk.
Aspirated pus growing E. coli, B. fragilis group, and Streptococcus anginosus is coherent for a colorectal source. A drain sample growing Candida, coagulase-negative staphylococci, and enterococci after three weeks in situ may reflect colonisation, unless the patient is septic and the sample came from a newly drained collection.
Candida is a common viva discussion. It is more likely to be clinically significant when isolated from a normally sterile intra-abdominal specimen taken at operation or fresh drainage, especially in critically ill patients, upper gastrointestinal perforation, recurrent perforation, pancreatitis, recent abdominal surgery, or prior broad-spectrum antibiotics. It is less convincing from old drains without clinical deterioration.
Treatment principles
Treatment has two pillars: source control and antimicrobial therapy. Antibiotics alone may suppress sepsis temporarily, but they often fail if a sizeable abscess remains undrained.
Source control is the decisive step
Source control means removing infected material and correcting the anatomical problem that caused it. Options include:
Percutaneous image-guided drainage
Laparoscopic washout and drainage
Open surgery for perforation, leak, necrosis, or uncontrolled contamination
Endoscopic biliary drainage for obstruction
Removal or exchange of infected prosthetic material, stents, or drains where appropriate
Debridement of necrotic tissue, such as infected pancreatic necrosis in selected cases
Percutaneous drainage is often preferred for accessible, well-defined collections. Surgery is more likely when there is generalised peritonitis, bowel perforation requiring repair, ischaemic bowel, failed percutaneous drainage, or complex multiloculated disease.
From the microbiology side, early discussion with surgeons and radiologists matters. A common and harmful failure mode is escalating antibiotics while delaying drainage.
Empirical antimicrobial therapy
Empirical treatment should cover the likely pathogens at the suspected source, then narrow when results return. In the UK, choices vary by local policy, resistance patterns, renal function, allergy history, and illness severity.
For community-acquired intra-abdominal sepsis, empirical regimens often need cover for:
Enterobacterales
Streptococci
Anaerobes
Examples used in UK practice may include co-amoxiclav, or a cephalosporin plus metronidazole, depending on local policy and severity. Gentamicin may be added in some protocols for severe sepsis, with careful monitoring. Piperacillin-tazobactam is commonly used for more severe infection or broader cover where indicated, subject to stewardship policies.
For healthcare-associated infection or high-risk patients, consider whether cover is needed for:
Pseudomonas aeruginosa
ESBL-producing Enterobacterales
Enterococcus species
Candida species
MRSA, if there are specific risk factors
Carbapenems such as meropenem should not be the default for every abscess. They are reasonable when there is severe sepsis with ESBL risk, previous resistant Gram-negative infection, or failure of narrower therapy where resistance is likely. The answer should show stewardship as well as safety.
Directed therapy after cultures
Once cultures and susceptibilities are available, narrow treatment where possible. Examples include:
E. coli susceptible to narrower beta-lactams plus anaerobic cover if polymicrobial bowel source remains likely
Streptococcus anginosus group abscess treated with a beta-lactam, with source control and assessment for polymicrobial infection
Enterococcus faecalis treated if clinically significant, often with amoxicillin if susceptible
ESBL-producing E. coli treated according to susceptibility, severity, and site, often requiring specialist input
Candida albicans treated if significant, often starting with an echinocandin in critically ill patients, then stepping down to fluconazole if susceptible and the patient improves
Do not stop anaerobic cover just because anaerobes were not isolated if culture conditions were suboptimal and the clinical source is colorectal. Anaerobes are fragile and may be missed, especially after antibiotics.
Duration of treatment
Duration depends on source control, clinical response, anatomy, and host factors.
After adequate source control and clinical improvement, short courses are often sufficient, commonly in the range of several days rather than weeks. Persistent fever or raised CRP alone should not automatically trigger prolonged broad-spectrum therapy. Look for inadequate drainage, an ongoing leak, thrombosis, drug fever, C. difficile, resistant organisms, or a non-infective mimic.
Longer treatment may be needed when source control is incomplete, there is undrained infection, associated osteomyelitis, endocarditis, actinomycosis, tuberculosis, or complex hepatobiliary disease.
Organisms that examiners expect you to know
A strong answer links microbiology to syndrome.
Bacteroides fragilis group
B. fragilis group organisms are important anaerobes in colonic perforation and pelvic abscesses. They produce beta-lactamases commonly, so metronidazole or beta-lactam beta-lactamase inhibitor combinations are often used, depending on susceptibility and context.
Do not rely on aminoglycosides for anaerobic infection. They have no useful anaerobic activity.
Streptococcus anginosus group
The S. anginosus group, including S. anginosus, S. constellatus, and S. intermedius, is associated with abscess formation. Isolation from blood should prompt a search for a deep focus, including intra-abdominal, hepatobiliary, dental, thoracic, or central nervous system sources.
Enterobacterales
E. coli and Klebsiella species are common in gut and biliary infection. Prior antibiotics, travel, healthcare exposure, and previous microbiology results influence ESBL risk. Susceptibility testing should drive de-escalation.
Enterococci
Enterococci are more likely to matter in healthcare-associated infection, biliary sepsis, postoperative infection, immunocompromised patients, and persistent infection after cephalosporin exposure. Enterococcus faecium is often more resistant than E. faecalis and may require glycopeptide or linezolid-style discussions depending on susceptibility and site.
Candida
Candida in intra-abdominal infection is a marker of severe disease in some contexts, but not every isolate needs treatment. For FRCPath, state the factors that make it significant: fresh sterile-site sample, compatible sepsis, high-risk abdominal pathology, critical illness, recurrent perforation, pancreatitis, or immunosuppression.
Less common but high-yield causes
Keep these in reserve when the presentation does not fit:
Entamoeba histolytica Consider with travel, migration, or exposure risk. Liver abscess fluid classically may be thick and brown, but diagnosis relies on serology and appropriate parasitology input. Treatment usually requires a tissue-active agent followed by a luminal agent.
Mycobacterium tuberculosis Consider in chronic abdominal collections, lymphadenopathy, constitutional symptoms, epidemiological risk, or immunosuppression.
Actinomyces Consider in chronic indurated infection, sinus tracts, intrauterine device association, or mass-like disease. Culture is difficult and prolonged therapy is often needed.
Burkholderia pseudomallei Consider melioidosis in compatible travel or residence history, diabetes, and visceral abscesses. This is uncommon in the UK but important not to miss.
Echinococcus Consider hydatid disease in cystic liver lesions with compatible epidemiology. Aspiration can be hazardous without specialist planning.
Case examples with exam lessons
Case 1 shows why source control beats escalation
A 68-year-old patient is admitted with perforated sigmoid diverticulitis and a 6 cm pelvic collection. They receive broad-spectrum antibiotics and improve for 24 hours, then remain febrile with rising CRP. Blood cultures are negative. CT confirms a persistent collection.
Interventional radiology drains pus. Gram stain shows many neutrophils, Gram-negative rods, Gram-positive cocci, and mixed anaerobic forms. Culture grows E. coli, B. fragilis group, and S. anginosus group.
The microbiology advice is to continue therapy covering Enterobacterales and anaerobes, narrow according to susceptibility, and review duration after clinical response and drain output. Further broadening without drainage would not have solved the main problem.
Exam lesson
When a collection is drainable, antibiotics are adjunctive. Persistent inflammation after 48 to 72 hours should trigger reassessment of source control, not automatic carbapenem escalation.
Case 2 shows why Candida interpretation needs context
A 59-year-old patient in intensive care has a postoperative leak after upper gastrointestinal surgery. They have received broad-spectrum antibiotics for several days and remain septic. At reoperation, peritoneal fluid grows Candida albicans and Enterococcus faecium, with mixed enteric organisms.
In this setting, Candida is more likely clinically significant because the sample is from a sterile intra-abdominal site during active sepsis after upper gastrointestinal surgery. Antifungal treatment is reasonable while susceptibility and response are reviewed. An echinocandin is often preferred initially in critically ill patients, with step-down if appropriate.
Exam lesson
Candida from a fresh operative sample in a septic high-risk patient is different from Candida from an old drain in a clinically improving patient.
Case 3 shows the value of syndrome-based thinking
A 42-year-old patient presents with fever and right upper quadrant pain. CT shows a liver abscess. Blood cultures grow Klebsiella pneumoniae. There is no obvious biliary obstruction on ultrasound.
Initial management includes antibiotics guided by susceptibility and consideration of percutaneous drainage depending on abscess size and response. The team also reassesses for diabetes, biliary disease, colorectal pathology if clinically indicated, and metastatic infection if symptoms suggest it.
Exam lesson
A liver abscess is not one syndrome. Biliary disease, portal spread, haematogenous infection, amoebiasis, and unusual pathogens need separate consideration.
What to say in an FRCPath Part 2 answer
A structured answer makes viva performance clearer. For a suspected intra-abdominal abscess, work through five headings.
Define the problem
State that this is a localised intra-abdominal collection of pus, often polymicrobial, commonly arising from bowel perforation, postoperative leak, hepatobiliary disease, or haematogenous spread.
Assess severity and source
Mention sepsis assessment, organ dysfunction, recent surgery, immunosuppression, antibiotic exposure, previous microbiology, and likely anatomical source.
Get the right samples
Ask for blood cultures if septic and pus or tissue from drainage or surgery. Request Gram stain, aerobic and anaerobic culture, susceptibility testing, and special tests when indicated. Avoid relying on superficial swabs or old drain cultures.
Treat early but do not ignore drainage
Start empirical antibiotics promptly in sepsis, with local guideline coverage for Gram-negative bacilli and anaerobes. Broaden for healthcare-associated risk factors when justified. Push for early imaging and source control.
Review and narrow
Review at 24 to 72 hours. Use cultures, imaging, clinical response, and source control status to narrow therapy and decide duration. If the patient does not improve, ask whether there is an undrained collection, ongoing leak, resistant pathogen, fungal infection, wrong diagnosis, or complication.
Early diagnosis changes outcomes
Delayed diagnosis allows abscesses to enlarge, bacteraemia to develop, organ dysfunction to progress, and surgical options to become more complex. Early diagnosis improves the chance of percutaneous drainage, limits unnecessary broad-spectrum antibiotic exposure, and reduces the time a patient spends septic.
From the microbiologist’s chair, the highest-value interventions are often simple:
Recognise the syndrome early.
Ask whether there is a drainable focus.
Get proper specimens before or at source control.
Cover likely organisms without ignoring stewardship.
Review culture results in relation to specimen quality.
Stop, narrow, or shorten therapy when the patient has improved and source control is adequate.
An intra-abdominal abscess is a test of clinical microbiology judgement. The safest answer balances urgency with precision: treat sepsis promptly, insist on source control, respect anaerobes, interpret cultures in context, and keep revisiting the source when the patient does not improve.
Comments